NCT05788341View on ClinicalTrials.gov

The Israeli Study for Islet Autoantibodies Screening in Families of Type-1 Diabetes Patients

RecruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

May 30, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions

Type 1 Diabetes

Trial Locations (1)

Unknown

RECRUITING

Schneider Children Medical Center of Israel, Petah Tikva

All Listed Sponsors

collaborator

Provention Bio, Inc.

INDUSTRY

lead

Rabin Medical Center

OTHER